MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$65,783K
(18.73%↑ Y/Y)
Net loss
-$65,783K
(18.73%↑ Y/Y)
Csl Seqirus
$65,982K
Other
$1,239K
Biomedical Advanced
Research And Development...
$13,236K
Gates Foundation
$1,574K
Net loss before
income taxes
-$65,783K
(18.73%↑ Y/Y)
Finance income, net
$10,095K
(-33.56%↓ Y/Y)
Gain (loss) from
foreign currency
$382K
(181.10%↑ Y/Y)
Collaboration Revenue
$67,221K
Grant
$14,810K
Loss from operations
-$76,260K
(20.29%↑ Y/Y)
Total revenue
$82,031K
(-46.14%↓ Y/Y)
Total operating
expenses
$158,291K
(-36.17%↓ Y/Y)
Research and
development, net
$112,212K
(-42.50%↓ Y/Y)
General and
administrative
$46,079K
(-12.77%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Arcturus Therapeutics Holdings Inc. (ARCT)
Arcturus Therapeutics Holdings Inc. (ARCT)